Abecma, Breyanzi, CARVYKTI, Kymiah, Tecartus, Yeskarta
Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha
Horudhac Qaybta Oncology, immunotherapy waxay u soo baxday hab horudhac ah, oo ka faa'iidaysanaysa habka difaaca jidhka si loola dagaallamo burooyinka halista ah. Waxaa jira habab badan oo difaaca jirka ah, laakiin Chimeric Antigen Rece.
Brexucabtagene autoleucel, Midowga Yurub, Gilecaad, Kite, Tecartus
Tecartus waxa uu siiyay ogolaanshaha suuqgeynta Yurub ee daawaynta soo noqoshada ama dib u soo noqoshada leukemia ba'an ee ba'an
Sebtembar 2022: Komishanka Yurub (EC) ayaa oggolaaday Kite's CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) daaweynta bukaannada qaangaarka ah ee da'doodu tahay 26 sano iyo wixii ka weyn ee leh soo noqoshada ama dib u celin (r/r) unugyada B-unugga.
Ball, Brexucabtagene autoleucel, Kite Pharma, Tecartus, ZUMA-3
Brexucabtagene autoleucel waxa u ansixisay FDA dib u soo noqoshada ama dib u soo noqoshada unugyada B-cell ee leukemia ba'an
Oktoobar 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) waxaa u ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanada qaangaarka ah ee soo noqnoqday ama dib u celinaya unugyada B-unugyada limfoblastic leukemia (ALL). Gudaha
Acalabrutunib, Avelumab, Daaweynta CART, Dabrafanib, Kymiah, Dawooyinka ugu dambeeyay, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Daawooyinka ugu dambeeyay ee daaweynta kansarka
Julaay 2021: Eeg dawooyinkii ugu dambeeyay ee daawaynta kansarka. Sannad kasta, ka dib marka la eego tijaabooyinka iyo arrimo kale oo muhiim ah, USFDA waxay ansixisay daawooyinka, sidaas awgeed bukaannada kansarka waxay hadda rumaysan karaan in daawadu aad u dhowdahay. ..